Abstract
BackgroundUntil now, no long-term studies relating serum albumin level to mortality rate in prevalent haemodialysis (HD) patients have been conducted. We aimed to examine the association between serum albumin level and mortality over a 5-year period.MethodsThis study included 781 patients who received maintenance HD in a large, hospital-facilitated HD centre. Five-year medical records (2009–2013) were retrospectively reviewed, and the cut-off level for serum albumin level was set at 3.5 g/dL. The analysed albumin levels were expressed as time-averaged levels (first 24-month data) and albumin target reach rate over the first 2-year interval. Univariate and multivariate Cox proportional hazard regression models were used to examine the hazard function of the all-cause and cardiovascular mortality of the study participants in the subsequent 3-year period (2011–2013).ResultsCompared to those with a 100 % albumin reach rate (3.5 g/dL), the participants with 75– < 100, 50– < 75, and 1– < 50 % albumin reach rates exhibited significantly increased risk for all-cause mortality (HR 1.72, 95 % CI 1.19–2.47; HR 3.14, 95 % CI 1.91–5.16; HR 3.66, 95 % CI 2.18–6.16, respectively). A similar trend for all-cause mortality was demonstrated in participants with time-averaged albumin levels <4 g/dL (HR 1.57, 95 % CI 1.00–2.46 for 3.5–4.0 g/dL; HR 3.66, 95 % CI 2.11–6.32 for <3.5 g/dL). Compared to a 100 % albumin reach rate, the 50– < 75 and 1– < 50 % groups (HR 4.28, 95 % CI 1.82–10.01; HR 3.23, 95 % CI 1.22–8.54 respectively) showed significantly higher cardiovascular mortality rates. Similarly, participants with a time-averaged serum albumin level <3.5 g/dL exhibited a higher risk for cardiovascular mortality (HR 3.24, 95 % CI: 1.23–8.56).ConclusionsThis long-term study demonstrated that higher reach rates of serum albumin levels and higher time-averaged serum albumin levels are associated with a lower mortality rate in patients undergoing maintenance HD.
Highlights
Until now, no long-term studies relating serum albumin level to mortality rate in prevalent haemodialysis (HD) patients have been conducted
We aimed to examine the association between time-averaged albumin and serum albumin reach rate in the first 2-year period and the risk of mortality in the subsequent 3-year period in prevalent haemodialysis (HD) patients
The present study investigated the association of 2-year serum albumin levels with mortality in a longitudinal 3-year period by utilizing the serum albumin reach rate for a predefined target level and the time-averaged albumin level
Summary
No long-term studies relating serum albumin level to mortality rate in prevalent haemodialysis (HD) patients have been conducted. We aimed to examine the association between serum albumin level and mortality over a 5-year period. There is accumulating evidence that the factors causing the low albumin levels, rather than hypoalbuminaemia per se, may be associated with high mortality and morbidity in dialysis patients [5, 6]. Several clinical conditions are associated with low serum albumin levels in dialysis patients, including infectious and inflammatory diseases [7, 8], fluid overload, inadequate dialysis [9], severe co-morbidity [10], and taste change [11]. One study that used time-dependent 2-year longitudinal change analysis noted that a drop in serum albumin levels during the first 6 months was associated with an increase in allcause and cardiovascular mortality in the subsequent months [2]. Current studies are limited by their short-term nature and relatively small sample sizes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have